Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
Domain I (DI) of beta-2-glycoprotein I (β2GPI) contains the immunodominant epitope for pathogenic antiphospholipid antibodies (aPL). DI is exposed in the linear form of the molecule but not in the circular form that comprises 90% of serum β2GPI. The majority of circulating β2GPI is biochemically red...
Main Authors: | Maria Gabriella Raimondo, Charis Pericleous, Anna Radziszewska, Maria Orietta Borghi, Silvia Pierangeli, Pier Luigi Meroni, Ian Giles, Anisur Rahman, Yiannis Ioannou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0186513 |
Similar Items
-
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
by: Thomas C. R. McDonnell, et al.
Published: (2018-10-01) -
Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
by: Thomas McDonnell, et al.
Published: (2018-09-01) -
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
by: Rohan Willis, et al.
Published: (2022-04-01) -
Pathogenesis of the obstetric antiphospholipid syndrome: the key role of beta 2 glycoprotein I
by: Pier Luigi Meroni, et al.
Published: (2022-08-01) -
Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
by: Laura Naranjo, et al.
Published: (2022-09-01)